B

Bioventus Inc
NASDAQ:BVS

Watchlist Manager
Bioventus Inc
NASDAQ:BVS
Watchlist
Price: 11.13 USD -0.27% Market Closed
Market Cap: 901.2m USD
Have any thoughts about
Bioventus Inc?
Write Note

Bioventus Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bioventus Inc
Revenue Peer Comparison

Comparables:
HAE
ICUI
ALGN
LNTH
MMSI

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
B
Bioventus Inc
NASDAQ:BVS
Revenue
$512.3m
CAGR 3-Years
17%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Haemonetics Corp
NYSE:HAE
Revenue
$1.4B
CAGR 3-Years
13%
CAGR 5-Years
7%
CAGR 10-Years
4%
ICU Medical Inc
NASDAQ:ICUI
Revenue
$2.3B
CAGR 3-Years
22%
CAGR 5-Years
12%
CAGR 10-Years
22%
Align Technology Inc
NASDAQ:ALGN
Revenue
$4B
CAGR 3-Years
2%
CAGR 5-Years
12%
CAGR 10-Years
18%
Lantheus Holdings Inc
NASDAQ:LNTH
Revenue
$1.5B
CAGR 3-Years
57%
CAGR 5-Years
34%
CAGR 10-Years
18%
Merit Medical Systems Inc
NASDAQ:MMSI
Revenue
$1.3B
CAGR 3-Years
8%
CAGR 5-Years
6%
CAGR 10-Years
10%

Bioventus Inc
Revenue Breakdown

Breakdown by Geography
Bioventus Inc

Total Revenue: 512.3m USD
100%
United States: 449.9m USD
87.8%
International: 62.5m USD
12.2%

Breakdown by Segments
Bioventus Inc

Not Available

See Also

What is Bioventus Inc's Revenue?
Revenue
512.3m USD

Based on the financial report for Dec 31, 2023, Bioventus Inc's Revenue amounts to 512.3m USD.

What is Bioventus Inc's Revenue growth rate?
Revenue CAGR 5Y
10%

Over the last year, the Revenue growth was 0%. The average annual Revenue growth rates for Bioventus Inc have been 17% over the past three years , 10% over the past five years .

Back to Top